Abstract
Background
The CREBRF missense variant (p.Arg457Gln) is paradoxically associated with lower risk of type 2 diabetes, yet higher body mass index (BMI). Here we sought to determine whether this CREBRF variant might be associated with adult height.
Methods
Linear regression was used to analyse the association of the CREBRF minor (A) allele with height in 2286 Māori and Pacific adults living in Aotearoa/New Zealand. A potential type 2 diabetes index event was corrected to account for a bias that may be the cause of paradoxical association between the CREBRF diabetes-protective allele and higher BMI and height.
Results
The CREBRF protective allele was associated with increased adult height (ß = 1.25 cm, P = 3.9 × 10−6), with the effect being more pronounced in males. The lower odds of diabetes remained similar when analyses were adjusted for height (OR = 0.67–0.65). We found no evidence of a diabetes index event bias to explain the paradoxical effect of CREBRF with either BMI or height and diabetes. The orthologous CREBRF p.Arg457Gln variant was created in knock-in mice to independently assess the effect of the variant, and length was found to be greater in male mice at 8 weeks of age.
Conclusion
These data taken together indicate that CREBRF p.Arg457Gln is associated with taller stature in Māori and Pacific adults.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Minster RL, Hawley NL, Su CT, Sun G, Kershaw EE, Cheng H, et al. A thrifty variant in CREBRF strongly influences body mass index in Samoans. Nat Genet. 2016;48:1049–54.
Krishnan M, Major TJ, Topless RK, Dewes O, Yu L, Thompson JMD, et al. Discordant association of the CREBRF rs373863828 A allele with increased BMI and protection from type 2 diabetes in Māori and Pacific (Polynesian) people living in Aotearoa/New Zealand. Diabetologia. 2018;61:1603–13.
Yaghootkar H, Bancks MP, Jones SE, McDaid A, Beaumont R, Donnelly L, et al. Quantifying the extent to which index event biases influence large genetic association studies. Hum Mol Genet. 2017;26:1018–30.
Berry SD, Walker CG, Ly K, Snell RG, Carr PEA, Bandara D, et al. Widespread prevalence of a CREBRF variant amongst Maori and Pacific children is associated with weight and height in early childhood. Int J Obes. 2018;42:603–7.
MoHNZNZVDR. 2017. https://www.health.govt.nz/our-work/diseases-and-conditions/diabetes/about-diabetes/virtual-diabetes-register-vdr.
Weedon MN, Lettre G, Freathy RM, Lindgren CM, Voight BF, Perry JR, et al. A common variant of HMGA2 is associated with adult and childhood height in the general population. Nature Genet. 2007;39:1245–50.
Martinelli CE, Keogh JM, Greenfield JR, Henning E, van der Klaauw AA, Blackwood A, et al. Obesity due to melanocortin 4 receptor (MC4R) deficiency is associated with increased linear growth and final height, fasting hyperinsulinemia, and incompletely suppressed growth hormone secretion. J Clin Endocrinol Metab. 2011;96:E181–8.
Thearle MS, Muller YL, Hanson RL, Mullins M, Abdussamad M, Tran J, et al. Greater impact of melanocortin-4 receptor deficiency on rates of growth and risk of type 2 diabetes during childhood compared with adulthood in Pima Indians. Diabetes. 2012;61:250–7.
Steinthorsdottir V, Thorleifsson G, Sulem P, Helgason H, Grarup N, Sigurdsson A, et al. Identification of low-frequency and rare sequence variants associated with elevated or reduced risk of type 2 diabetes. Nat Genet. 2014;46:294–8.
Yaghootkar H, Stancakova A, Freathy RM, Vangipurapu J, Weedon MN, Xie W, et al. Association analysis of 29,956 individuals confirms that a low-frequency variant at CCND2 halves the risk of type 2 diabetes by enhancing insulin secretion. Diabetes. 2015;64:2279–85.
Funding
The Health Research Council of New Zealand (grant no 08/075, 10/548, 11/1075, 14/527) and the Maurice Wilkins Centre funded this study. LKM is supported by an Australian Research Training Program Scholarship. HY is funded by Diabetes UK RD Lawrence fellowship (grant 17/0005594). The funders had no role in the study design, interpretation or in the decision to submit these results for publication.
Author information
Authors and Affiliations
Contributions
RM, LKM, MK, HY, TM and PS contributed to the design of the study. OD, ND, LKS, JHH, JDZ, RM contributed to participant data collection. PS, GS, TLM, LKM and NT contributed to animal data collection. RM and MK drafted the paper and all authors reviewed this. The paper was approved by all authors.
Corresponding author
Ethics declarations
Conflict of interest
The authors declare that they have no conflict of interest.
Additional information
Publisher’s note: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Metcalfe, L.K., Krishnan, M., Turner, N. et al. The Māori and Pacific specific CREBRF variant and adult height. Int J Obes 44, 748–752 (2020). https://doi.org/10.1038/s41366-019-0437-6
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/s41366-019-0437-6
This article is cited by
-
Molecular characterization of mouse CREB3 regulatory factor in Neuro2a cells
Molecular Biology Reports (2021)
-
The CREBRF diabetes-protective rs373863828-A allele is associated with enhanced early insulin release in men of Māori and Pacific ancestry
Diabetologia (2021)
-
The Pacific-specific CREBRF rs373863828 allele protects against gestational diabetes mellitus in Māori and Pacific women with obesity
Diabetologia (2020)